| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Shultz, M. E., et al.
(författare)
-
Ultraviolet spectropolarimetry with Polstar : using Polstar to test magnetospheric mass-loss quenching
- 2022
-
Ingår i: Astrophysics and Space Science. - : Springer Nature. - 0004-640X .- 1572-946X. ; 367:12
-
Tidskriftsartikel (refereegranskat)abstract
- Polstar is a proposed NASA MIDEX space telescope that will provide high-resolution, simultaneous full-Stokes spectropolarimetry in the far ultraviolet, together with low-resolution linear polarimetry in the near ultraviolet. This observatory offers unprecedented capabilities to obtain unique information on the magnetic and plasma properties of the magnetospheres of hot stars. We describe an observing program making use of the known population of magnetic hot stars to test the fundamental hypothesis that magnetospheres should act to rapidly drain angular momentum, thereby spinning the star down, whilst simultaneously reducing the net mass-loss rate. Both effects are expected to lead to dramatic differences in the evolution of magnetic vs. non-magnetic stars.
|
|
| 5. |
- David-Uraz, A., et al.
(författare)
-
Magnetic OB[A] Stars with TESS : probing their Evolutionary and Rotational properties (MOBSTER) - I. First-light observations of known magnetic B and A stars
- 2019
-
Ingår i: Monthly notices of the Royal Astronomical Society. - : Oxford University Press (OUP). - 0035-8711 .- 1365-2966. ; 487:1, s. 304-317
-
Tidskriftsartikel (refereegranskat)abstract
- In this paper we introduce the MOBSTER collaboration and lay out its scientific goals. We present first results based on the analysis of 19 previously known magnetic O, B, and A stars observed in 2-min cadence in sectors 1 and 2 of the Transiting Exoplanet Survey Satellite (TESS) mission. We derive precise rotational periods from the newly obtained light curves and compare them to previously published values. We also discuss the overall photometric phenomenology of the known magnetic massive and intermediate-mass stars and propose an observational strategy to augment this population by taking advantage of the high-quality observations produced by TESS.
|
|
| 6. |
- Blomstrom-Lundqvist, C., et al.
(författare)
-
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
- 2020
-
Ingår i: European Heart Journal. - : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 41:21, s. 2012-2032
-
Tidskriftsartikel (refereegranskat)abstract
- Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially lifesaving treatments for a number of cardiac conditions but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased health care costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well-recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket antibiotic solutions, antibacterial envelopes, prolonged antibiotics post-implantation, and others. When compared with previous guidelines or consensus statements, the present consensus document gives guidance on the use of novel device alternatives, novel oral anticoagulants, antibacterial envelopes, prolonged antibiotics post-implantation, as well as definitions on minimum quality requirements for centres and operators and volumes. The recognition that an international consensus document focused on management of CIED infections is lacking, the dissemination of results from new important randomized trials focusing on prevention of CIED infections, and observed divergences in managing device-related infections as found in an European Heart Rhythm Association worldwide survey, provided a strong incentive for a Novel 2019 International State-of-the-art Consensus document on risk assessment, prevention, diagnosis, and treatment of CIED infections.
|
|
